|
MechanismMC4R antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Obexia AG In Liquidation
0 Patents (Medical) associated with Obexia AG In Liquidation
100 Deals associated with Obexia AG In Liquidation
100 Translational Medicine associated with Obexia AG In Liquidation